Gopalkumar Rakesh
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Gopalkumar Rakesh sits in the upper quartile of US sponsors by registered trial count (#1,806 of 15,742 sponsors by registered trial count).
Gopalkumar Rakesh: 7 sponsored US clinical trials, 2 recruiting.
Gopalkumar Rakesh sponsors 7 registered US clinical trials on ClinicalTrials.gov, 2 of them currently recruiting, and 5 completed. The most-studied condition in this pipeline is Methamphetamine Use Disorders, with 1 trials.
Upper-quartile sponsor footprint
Gopalkumar Rakesh sits in the upper quartile of the sponsor corpus (#1,806 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
7 total, page 1 of 1
tDCS and Urge in BFRBs
NCT07019571
Transcranial Magnetic Stimulation for Methamphetamine Use Disorder in PLWH
NCT06830980
tDCS and Inhibitory Control in PTSD
NCT06100731
Theta Burst Stimulation for Alcohol Use Disorder
NCT06060496
Accelerated Transcranial Magnetic Stimulation (TMS) for Smoking Cessation in People Living With HIV/AIDS (PLWHA)
NCT05295953
Adjunctive Transcranial Stimulation to Reduce Impulsivity in Opiate Use Disorder
NCT05049460
TMS for Smoking Cessation in PLWHA Cessation in People Living With HIV/AIDS (PLWHA)
NCT04936594
Therapeutic Areas
What is open in the Gopalkumar Rakesh pipeline
2 recruiting of 7 indexed (29% open); 5 completed (71%).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Methamphetamine Use Disorders (1 trial), 2 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Gopalkumar Rakesh: open-pipeline peers nationwide
Peers matched on 7 registered trials and 29% open enrollment, not the therapeutic-area sidebar.
Gopalkumar Rakesh sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 7 trials (± recruiting share)
- 3M · 7 trials · 0% recruiting
- 4Life Research · 7 trials · 0% recruiting
- 89bio · 7 trials · 29% recruiting
- Abbott Diagnostics Division · 7 trials · 0% recruiting
Sponsors near 29% open enrollment (± trial volume)
- Alabama Physical Therapy & Acupuncture · 29% recruiting · 14 trials
- AlloSource · 29% recruiting · 7 trials
- Alnylam Pharmaceuticals · 29% recruiting · 49 trials
- Annovis Bio · 29% recruiting · 7 trials
Related
What to do with this Gopalkumar Rakesh page
7 registered trials is a research-attention snapshot, not an endorsement of Gopalkumar Rakesh or any single study.
- 2 of Gopalkumar Rakesh's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Methamphetamine Use Disorders is the condition Gopalkumar Rakesh studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Methamphetamine Use Disorders trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Gopalkumar Rakesh pipeline card: 7 registered trials from official public datasets.Report a data error.